Curtin University Homepage
  • Library
  • Help
    • Admin

    espace - Curtin’s institutional repository

    JavaScript is disabled for your browser. Some features of this site may not work without it.
    View Item 
    • espace Home
    • espace
    • Curtin Research Publications
    • View Item
    • espace Home
    • espace
    • Curtin Research Publications
    • View Item

    Sclerotherapy in tumescent anesthesia of reticular veins and telangiectasias

    Access Status
    Fulltext not available
    Authors
    Ramelet, Anne-Sylvie
    Date
    2012
    Type
    Journal Article
    
    Metadata
    Show full item record
    Citation
    Ramelet, A. 2012. Sclerotherapy in tumescent anesthesia of reticular veins and telangiectasias. Dermatologic Surgery. 38 (5): pp. 748-751.
    Source Title
    Dermatologic Surgery
    DOI
    10.1111/j.1524-4725.2011.02287.x
    ISSN
    1076-0512
    School
    School of Nursing and Midwifery
    URI
    http://hdl.handle.net/20.500.11937/7032
    Collection
    • Curtin Research Publications
    Abstract

    Background Some leg telangiectasias may be refractory to treatment, including sclerotherapy and lasers. Objective To describe the innovative Sclerotherapy in Tumescent Anesthesia of Reticular veins and Telangiectasias (START) approach to achieving good results in such patients, which also proves effective in treating reticular veins. Method Because compression enhances the rate of success of sclerotherapy of C1 veins (telangiectasias and reticular), Ringer solution (with or without lidocaine-epinephrine) was injected subcutaneously before, during, or immediately after sclerotherapy of therapy-refractory C1 veins. This tumescence ensures an intratissular compression of the injected vessels for at least 1 hour. Results In the last 6 years, we have treated more than 300 patients. Telangiectasias that had resisted several previous treatments faded or disappeared in the majority of the cases treated, but the rate of complications (pigmentation, necrosis of small areas, and tiny scars) was higher than with usual sclerotherapy. Conclusion Developed after observing the good results achieved by perioperative sclerotherapy of telangiectasias during ambulatory phlebectomy, the START technique is an effective and economic treatment of therapy-resistant telangiectasias, although because the rate of complications is higher than with usual sclerotherapy of C1 veins, it should be performed only by experienced phlebologists and only on therapy-refractory vessels. © 2012 by the American Society for Dermatologic Surgery, Inc. Published by Wiley Periodicals, Inc.

    Related items

    Showing items related by title, author, creator and subject.

    • A double-blind, randomized study comparing pure chromated glycerin with chromated glycerin with 1% lidocaine and epinephrine for sclerotherapy of telangiectasias and reticular veins
      Kern, P.; Ramelet, Anne-Sylvie; Wutschert, R.; Mazzolai, L. (2011)
      Background: Chromated glycerin (CG) is an effective, although painful, sclerosing agent for telangiectasias and reticular leg veins treatment. OBJECTIVE To determine pain level and relative efficacy of pure or one-third ...
    • Muller's phlebectomy
      Ramelet, Anne-Sylvie; Perruchoud, D. (2014)
      © Schattauer 2014. More than 50 years ago, the Swiss dermatologist Dr Robert Muller developed ambulatory phlebectomy, a brilliant demonstration of the major role of dermatologists in the field of phlebology. The technique ...
    • The START technique
      Ramelet, Anne-Sylvie (2012)
      Aims: Sclerotherapy is the treatment of choice for telangiectasia of the lower limbs, after elimination of the perforating feeding veins. However, telangiectasia may be refractory to even well-managed treatment, and ...
    Advanced search

    Browse

    Communities & CollectionsIssue DateAuthorTitleSubjectDocument TypeThis CollectionIssue DateAuthorTitleSubjectDocument Type

    My Account

    Admin

    Statistics

    Most Popular ItemsStatistics by CountryMost Popular Authors

    Follow Curtin

    • 
    • 
    • 
    • 
    • 

    CRICOS Provider Code: 00301JABN: 99 143 842 569TEQSA: PRV12158

    Copyright | Disclaimer | Privacy statement | Accessibility

    Curtin would like to pay respect to the Aboriginal and Torres Strait Islander members of our community by acknowledging the traditional owners of the land on which the Perth campus is located, the Whadjuk people of the Nyungar Nation; and on our Kalgoorlie campus, the Wongutha people of the North-Eastern Goldfields.